Abstract: Provided is method of providing a conversation service in an electronic apparatus, including receiving a conversation input from a user terminal, identifying conversation history information associated with a user of the user terminal, obtaining score information corresponding to the user based on the conversation input and the conversation history information, obtaining response information based on the conversation input and the conversation history information, and providing the user terminal with at least one of the score information and the response information.

Abstract: Disclosed are a drunk driving prevention system and a method of controlling the system that includes a sensor module measuring a alcohol content in the exhaled breath of a driver during a breath-checking of the driver and a control module configured to check the intoxication state of the driver from the alcohol content measured by the sensor module to determine whether the breath-checking is complete and block an engine start when the breath-checking fails, wherein the control module includes a check unit displaying breath-checking guide information through a display unit and the check unit displays the breath-checking guide information based on an engine start input of the driver.

Abstract: A wafer manufacturing method, an epitaxial wafer manufacturing method, and a wafer and epitaxial wafer manufactured thereby, are provided. The wafer manufacturing method enables the manufacture of a wafer with a low density of micropipe defects and minimum numbers of particles and scratches. The epitaxial wafer manufacturing method enables the manufacture of an epitaxial wafer that has low densities of defects such as downfall, triangular, and carrot defects, exhibits excellent device characteristics, and improves the yield of devices.

Abstract: An embodiment sulfur dioxide-based inorganic electrolyte is provided in which the sulfur dioxide-based inorganic electrolyte is represented by a chemical formula M·(A1·Cl(4-x)Fx)z·ySO2. In this formula, M is a first element selected from the group consisting of Li, Na, K, Ca, and Mg, A1 is a second element selected from the group consisting of Al, Fe, Ga, and Cu, x satisfies a first equation 0?x?4, y satisfies a second equation 0?y?6, and z satisfies a third equation 1?z?2.

Abstract: A wafer manufacturing method, an epitaxial wafer manufacturing method, and a wafer and epitaxial wafer manufactured thereby, are provided. The wafer manufacturing method enables the manufacture of a wafer with a low density of micropipe defects and minimum numbers of particles and scratches. The epitaxial wafer manufacturing method enables the manufacture of an epitaxial wafer that has low densities of defects such as downfall, triangular, and carrot defects, exhibits excellent device characteristics, and improves the yield of devices.

Abstract: The present invention relates to a method for assessing the prognosis or risk stratification of liver cancer by using a clinical specimen mixed with a normal tissue, wherein at least one CpG site that shows a low methylation level in normal and blood tissues but a high methylation level in only a cancer tissue is measured for methylation level.

Abstract: The present invention relates to a method for assessing the prognosis or risk stratification of liver cancer by using a clinical specimen mixed with a normal tissue, wherein at least one CpG site that shows a low methylation level in normal and blood tissues but a high methylation level in only a cancer tissue is measured for methylation level.

Abstract: The present invention relates to: a composition for detecting a gastric cancer marker comprising a preparation for measuring the expression level or methylation level of mRNA of ADCY3 or a protein thereof; a kit for diagnosing gastric cancer, containing the composition; a method for diagnosing gastric cancer by treating a biological sample with the preparation to ascertain whether a material for complementarily binding to the preparation exists and comparing the amount thereof with a control group; a composition for treating and preventing gastric cancer, containing a preparation capable of inhibiting ADCY3 polynucleotide or ADCY3 polypeptide; and a method for treating gastric cancer by administering the composition to an individual. According to the present invention, it is possible to diagnose gastric cancer with high diagnostic sensitivity and specificity using ADCY3 as a marker for diagnosing gastric cancer, and thus can greatly contribute to reducing mortality due to gastric cancer.

Abstract: The present invention relates to statistical machine translation, and provides a machine translation device and a machine translation method that acquire a creation probability for a target language from a single corpus while extracting respective conversion probabilities by extracting syntax conversion knowledge and word translation knowledge from a parallel corpus, model a weighted translation model by allowing each of the conversion knowledge and each of the probabilities to learn using a translation model learning device, and generate a target sentence through decoding processes of a syntax converter and a word translator by applying the translation model to a source sentence input in real time, thereby resolving disadvantages of the existing phrase-based SMT and syntax-based SMT and combining advantages thereof.

Abstract: The present invention relates to a method of predicting reaction to Sorafenib treatment using genetic polymorphism. More specifically, for the reaction to Sorafenib treatment according to the present invention, it is possible to predict the reaction of a test object to Sorafenib treatment by using an anticancer-target gene which is expressed in a biological sample of a liver cancer patient as a biomarker, whereby a proper drug is administered to a liver cancer patient and an optimal treatment effect is attained, so that inconvenience of a patient can be reduced, costs for treatment can be reduced, and an individually tailored chemotherapy can more effectively be implemented by administration of a patient-specific anticancer agent.

Abstract: In an air purifying apparatus for removing contaminants, such as soot and the like, by burning contaminated air while passing the contaminated air through a filter heated by microwaves, the apparatus includes: a housing, which is hollow, and comprises an inlet on one side and an outlet on the other side; a ceramic filter of a longitudinal material, which is arranged in the housing in a longitudinal direction of the housing, and includes a plurality of partition walls formed so that a flow path where contaminated air flows may be divided in plurality; and a microwave generator configured to generate microwaves to be supplied to one end surface of the ceramic filter in a longitudinal direction thereof to heat the one end surface of the ceramic filter in the longitudinal direction.

Abstract: The present invention relates to: a composition for detecting a gastric cancer marker comprising a preparation for measuring the expression level or methylation level of mRNA of ADCY3 or a protein thereof; a kit for diagnosing gastric cancer, containing the composition; a method for diagnosing gastric cancer by treating a biological sample with the preparation to ascertain whether a material for complementarily binding to the preparation exists and comparing the amount thereof with a control group; a composition for treating and preventing gastric cancer, containing a preparation capable of inhibiting ADCY3 polynucleotide or ADCY3 polypeptide; and a method for treating gastric cancer by administering the composition to an individual. According to the present invention, it is possible to diagnose gastric cancer with high diagnostic sensitivity and specificity using ADCY3 as a marker for diagnosing gastric cancer, and thus can greatly contribute to reducing mortality due to gastric cancer.

Abstract: Disclosed is a method for screening a novel cancer therapeutic agent. The cancer therapeutic agent exhibits down-regulation of galectin-3 and fascin-1 or interferes with the interaction between galectin-3 and GSK-3?.

Abstract: In an air purifying apparatus for removing contaminants, such as soot and the like, by burning contaminated air while passing the contaminated air through a filter heated by microwaves, the apparatus includes: a housing, which is hollow, and comprises an inlet on one side and an outlet on the other side; a ceramic filter of a longitudinal material, which is arranged in the housing in a longitudinal direction of the housing, and includes a plurality of partition walls formed so that a flow path where contaminated air flows may be divided in plurality; and a microwave generator configured to generate microwaves to be supplied to one end surface of the ceramic filter in a longitudinal direction thereof to heat the one end surface of the ceramic filter in the longitudinal direction.

Abstract: Disclosed are a cancer marker-detecting composition comprising an agent for measuring an mRNA or protein expression level of eIF3m, a cancer diagnosis kit comprising the same, a method for detecting an eIF3m polynucleotide or protein by treating a biological specimen with the agent to detect a substance binding specifically to the agent and quantitatively comparing the substance between a subject and a normal control, and a method for the treatment and prevention of cancer comprising an agent for down-regulating the expression of an eIF3m polynucleotide or protein.

Abstract: Provided are a method and apparatus for analyzing genotype data plotted in a two-dimensional space. The method includes: connecting points representing the genotype data to a predetermined point to form straight lines and obtaining angles between adjacent straight lines; extracting the two largest angles from the obtained angles; and analyzing the plotted genotype data using three groups of the genotype data separated by the two extracted largest angles. According to the present invention, when the experimental results of classifying genotype are to be analyzed, the two largest angles from the angles obtained by connecting straight lines between points representing each of the genotype data and a predetermined point plotted in a two-dimensional space are detected, and three data regions separated by the detected two largest angles are used to analyze the genotype data. Thus, a large amount of the experimental data for classifying the genotype can be analyzed rapidly and conveniently.

Abstract: Disclosed herein is a composition for molecular imaging comprising a trans-splicing ribozyme coupled with an imaging reporter gene. The trans-splicing ribozyme targets a specific gene associated with a disease. Also disclosed is a molecular imaging method using the composition.

Abstract: The present invention relates to statistical machine translation, and provides a machine translation device and a machine translation method that acquire a creation probability for a target language from a single corpus while extracting respective conversion probabilities by extracting syntax conversion knowledge and word translation knowledge from a parallel corpus, model a weighted translation model by allowing each of the conversion knowledge and each of the probabilities to learn using a translation model learning device, and generate a target sentence through decoding processes of a syntax converter and a word translator by applying the translation model to a source sentence input in real time, thereby resolving disadvantages of the existing phrase-based SMT and syntax-based SMT and combining advantages thereof.

Abstract: Disclosed are a cancer marker-detecting composition comprising an agent for measuring an mRNA or protein expression level of eIF3m, a cancer diagnosis kit comprising the same, a method for detecting an eIF3m polynucleotide or protein by treating a biological specimen with the agent to detect a substance binding specifically to the agent and quantitatively comparing the substance between a subject and a normal control, and a method for the treatment and prevention of cancer comprising an agent for down-regulating the expression of an eIF3m polynucleotide or protein.

Abstract: Disclosed is a method for screening a novel cancer therapeutic agent. The cancer therapeutic agent exhibits down-regulation of galectin-3 and fascin-1 or interferes with the interaction between galectin-3 and GSK-3?.